| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulonephritis | 19 | 2022 | 80 | 3.860 |
Why?
|
| Receptors, Complement | 28 | 2014 | 46 | 3.620 |
Why?
|
| Complement System Proteins | 20 | 2025 | 86 | 3.380 |
Why?
|
| Complement Factor H | 17 | 2022 | 34 | 3.280 |
Why?
|
| Complement Activation | 26 | 2025 | 84 | 2.800 |
Why?
|
| Kidney Glomerulus | 25 | 2016 | 122 | 2.500 |
Why?
|
| Complement Inactivator Proteins | 16 | 2021 | 27 | 2.300 |
Why?
|
| Complement C3 | 20 | 2020 | 58 | 2.150 |
Why?
|
| Kidney | 23 | 2022 | 1135 | 2.000 |
Why?
|
| Lupus Nephritis | 9 | 2013 | 79 | 1.820 |
Why?
|
| Antigen-Antibody Complex | 10 | 2015 | 89 | 1.690 |
Why?
|
| Receptor, Anaphylatoxin C5a | 10 | 2020 | 21 | 1.680 |
Why?
|
| Receptors, Complement 3b | 22 | 2010 | 39 | 1.610 |
Why?
|
| Kidney Diseases | 11 | 2021 | 323 | 1.590 |
Why?
|
| Lupus Erythematosus, Systemic | 14 | 2017 | 235 | 1.540 |
Why?
|
| Immune Complex Diseases | 6 | 2022 | 20 | 1.370 |
Why?
|
| Mice | 77 | 2022 | 12537 | 1.280 |
Why?
|
| Immunoglobulin G | 14 | 2015 | 481 | 1.270 |
Why?
|
| Animals | 112 | 2025 | 28889 | 1.250 |
Why?
|
| Complement C3a | 4 | 2018 | 11 | 1.210 |
Why?
|
| Complement C5a | 10 | 2020 | 24 | 1.170 |
Why?
|
| Disease Models, Animal | 26 | 2018 | 2534 | 1.160 |
Why?
|
| Glomerulonephritis, Membranous | 5 | 2013 | 23 | 1.140 |
Why?
|
| Mice, Inbred C57BL | 33 | 2022 | 3491 | 1.010 |
Why?
|
| Diabetic Nephropathies | 4 | 2011 | 90 | 0.910 |
Why?
|
| Serum Sickness | 6 | 2015 | 12 | 0.870 |
Why?
|
| Reperfusion Injury | 5 | 2014 | 148 | 0.840 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 5 | 2016 | 11 | 0.770 |
Why?
|
| Blood Platelets | 6 | 2010 | 154 | 0.760 |
Why?
|
| CD55 Antigens | 3 | 2009 | 21 | 0.750 |
Why?
|
| Apoptosis | 17 | 2016 | 1756 | 0.740 |
Why?
|
| CD59 Antigens | 7 | 2009 | 17 | 0.740 |
Why?
|
| Mice, Inbred MRL lpr | 16 | 2016 | 37 | 0.720 |
Why?
|
| Acute Kidney Injury | 6 | 2004 | 341 | 0.710 |
Why?
|
| Mice, Knockout | 21 | 2022 | 2161 | 0.700 |
Why?
|
| Monocytes | 3 | 2018 | 220 | 0.670 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 6 | 2012 | 16 | 0.660 |
Why?
|
| Brain | 13 | 2016 | 2480 | 0.660 |
Why?
|
| Complement C5 | 3 | 2011 | 14 | 0.660 |
Why?
|
| Up-Regulation | 9 | 2017 | 740 | 0.640 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2021 | 258 | 0.640 |
Why?
|
| Glomerular Mesangium | 4 | 2008 | 21 | 0.630 |
Why?
|
| Rats | 26 | 2012 | 4154 | 0.610 |
Why?
|
| Neutrophils | 6 | 2009 | 328 | 0.600 |
Why?
|
| Podocytes | 6 | 2012 | 34 | 0.570 |
Why?
|
| Kidney Failure, Chronic | 4 | 2021 | 432 | 0.550 |
Why?
|
| CD11b Antigen | 2 | 2015 | 38 | 0.530 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 2061 | 0.520 |
Why?
|
| Inflammation | 8 | 2018 | 1063 | 0.520 |
Why?
|
| Brain Diseases, Metabolic | 2 | 2007 | 8 | 0.500 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2009 | 36 | 0.500 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2008 | 701 | 0.500 |
Why?
|
| Nephritis, Interstitial | 5 | 2011 | 44 | 0.480 |
Why?
|
| Leukocytes | 3 | 2015 | 213 | 0.480 |
Why?
|
| Apoferritins | 7 | 2022 | 15 | 0.470 |
Why?
|
| Carboxypeptidases | 1 | 2015 | 34 | 0.460 |
Why?
|
| Amino Acids | 2 | 2007 | 262 | 0.460 |
Why?
|
| Macrophages | 6 | 2022 | 623 | 0.460 |
Why?
|
| Receptors, Cell Surface | 11 | 2005 | 297 | 0.450 |
Why?
|
| Cells, Cultured | 16 | 2017 | 2929 | 0.440 |
Why?
|
| Hepatitis B | 1 | 2015 | 82 | 0.440 |
Why?
|
| Hepatitis C | 2 | 2015 | 184 | 0.440 |
Why?
|
| Receptors, IgG | 1 | 2015 | 68 | 0.430 |
Why?
|
| NF-kappa B | 6 | 2015 | 469 | 0.430 |
Why?
|
| Complement Pathway, Alternative | 4 | 2021 | 13 | 0.420 |
Why?
|
| Neutrophil Infiltration | 3 | 2009 | 33 | 0.410 |
Why?
|
| Blood-Brain Barrier | 6 | 2015 | 80 | 0.410 |
Why?
|
| Endothelium, Vascular | 5 | 2016 | 437 | 0.410 |
Why?
|
| Kidney Transplantation | 7 | 2009 | 882 | 0.400 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2013 | 21 | 0.400 |
Why?
|
| Kidney Tubules | 3 | 2010 | 91 | 0.400 |
Why?
|
| T-Lymphocytes | 4 | 2012 | 1310 | 0.400 |
Why?
|
| Receptors, Complement 3d | 6 | 2009 | 14 | 0.400 |
Why?
|
| Glucose | 2 | 2007 | 701 | 0.390 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 2473 | 0.390 |
Why?
|
| RNA, Messenger | 16 | 2010 | 2089 | 0.390 |
Why?
|
| Antibodies, Antinuclear | 3 | 2010 | 95 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2010 | 712 | 0.380 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2003 | 564 | 0.360 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 1006 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 1230 | 0.360 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2009 | 60 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 7 | 2010 | 1124 | 0.350 |
Why?
|
| Erythrocytes | 2 | 2010 | 252 | 0.350 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 84 | 0.340 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 453 | 0.330 |
Why?
|
| Gene Expression Profiling | 7 | 2014 | 1535 | 0.330 |
Why?
|
| MicroRNAs | 3 | 2014 | 591 | 0.330 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 70 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2010 | 25 | 0.320 |
Why?
|
| Lipopolysaccharides | 5 | 2007 | 305 | 0.320 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2007 | 43 | 0.310 |
Why?
|
| Signal Transduction | 11 | 2016 | 3581 | 0.310 |
Why?
|
| Receptors, Fc | 1 | 2009 | 40 | 0.300 |
Why?
|
| Mesangial Cells | 1 | 2009 | 9 | 0.300 |
Why?
|
| Pichia | 3 | 2003 | 31 | 0.300 |
Why?
|
| Mice, Transgenic | 10 | 2010 | 1645 | 0.290 |
Why?
|
| Serum Albumin | 1 | 2009 | 127 | 0.290 |
Why?
|
| Clusterin | 2 | 2008 | 14 | 0.290 |
Why?
|
| Antigens, Surface | 10 | 2005 | 104 | 0.290 |
Why?
|
| RNA Splicing | 1 | 2010 | 159 | 0.290 |
Why?
|
| Complement Factor B | 2 | 2012 | 9 | 0.290 |
Why?
|
| Blood Urea Nitrogen | 4 | 2010 | 34 | 0.280 |
Why?
|
| Kidney Function Tests | 4 | 2016 | 116 | 0.280 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 209 | 0.280 |
Why?
|
| Fibronectins | 1 | 2008 | 100 | 0.270 |
Why?
|
| Sepsis | 3 | 2007 | 389 | 0.270 |
Why?
|
| bcl-X Protein | 1 | 2007 | 55 | 0.270 |
Why?
|
| Atherosclerosis | 1 | 2011 | 267 | 0.270 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 590 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 416 | 0.270 |
Why?
|
| Antigens, CD | 2 | 2002 | 480 | 0.260 |
Why?
|
| Humans | 42 | 2025 | 95802 | 0.260 |
Why?
|
| Encephalitis | 1 | 2007 | 101 | 0.260 |
Why?
|
| Male | 33 | 2020 | 45686 | 0.260 |
Why?
|
| Dysbiosis | 2 | 2018 | 91 | 0.250 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 483 | 0.250 |
Why?
|
| Behavior, Animal | 2 | 2007 | 394 | 0.250 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 23 | 0.250 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 161 | 0.240 |
Why?
|
| Endotoxemia | 2 | 2004 | 19 | 0.240 |
Why?
|
| Lupus Vulgaris | 1 | 2005 | 4 | 0.240 |
Why?
|
| Albuminuria | 4 | 2009 | 51 | 0.240 |
Why?
|
| Transgenes | 3 | 2009 | 186 | 0.230 |
Why?
|
| Vitamin D | 2 | 2007 | 273 | 0.220 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 232 | 0.220 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 270 | 0.220 |
Why?
|
| Diacylglycerol Kinase | 2 | 2016 | 5 | 0.220 |
Why?
|
| Autoimmune Diseases | 2 | 2004 | 257 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2007 | 1267 | 0.210 |
Why?
|
| Renal Insufficiency | 3 | 2011 | 99 | 0.210 |
Why?
|
| Aquaporins | 1 | 2003 | 14 | 0.210 |
Why?
|
| Complement Inactivating Agents | 2 | 2025 | 7 | 0.200 |
Why?
|
| Bacteria | 2 | 2018 | 517 | 0.200 |
Why?
|
| Fibrosis | 4 | 2022 | 235 | 0.200 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3040 | 0.200 |
Why?
|
| Base Sequence | 8 | 2012 | 2342 | 0.200 |
Why?
|
| Curcumin | 2 | 2013 | 16 | 0.200 |
Why?
|
| Energy Metabolism | 1 | 2005 | 312 | 0.190 |
Why?
|
| Leukemia Virus, Murine | 1 | 2002 | 18 | 0.190 |
Why?
|
| Solubility | 5 | 2003 | 190 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2007 | 130 | 0.190 |
Why?
|
| Retroviridae | 1 | 2002 | 76 | 0.190 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 20 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 90 | 0.180 |
Why?
|
| Chemokines | 3 | 2007 | 77 | 0.180 |
Why?
|
| Gene Expression | 7 | 2020 | 1319 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 897 | 0.180 |
Why?
|
| Pinocytosis | 1 | 2021 | 6 | 0.180 |
Why?
|
| Lymphocyte Depletion | 2 | 2013 | 101 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2005 | 1275 | 0.180 |
Why?
|
| Renal Circulation | 1 | 2001 | 37 | 0.170 |
Why?
|
| Cresols | 1 | 2021 | 17 | 0.170 |
Why?
|
| DNA Primers | 6 | 2008 | 548 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2010 | 89 | 0.170 |
Why?
|
| Cytokines | 5 | 2017 | 871 | 0.170 |
Why?
|
| Antibodies | 4 | 2009 | 356 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 556 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2013 | 983 | 0.170 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2000 | 23 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2002 | 187 | 0.170 |
Why?
|
| Physical Endurance | 1 | 2020 | 12 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 142 | 0.160 |
Why?
|
| Endothelial Cells | 4 | 2021 | 477 | 0.160 |
Why?
|
| Aorta | 1 | 2021 | 294 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 246 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 557 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2011 | 40 | 0.150 |
Why?
|
| Ischemia | 1 | 2001 | 256 | 0.150 |
Why?
|
| Endothelium | 2 | 2016 | 60 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2009 | 1425 | 0.150 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2090 | 0.150 |
Why?
|
| Cerebrospinal Fluid | 1 | 1999 | 30 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 825 | 0.150 |
Why?
|
| Uremia | 1 | 2018 | 14 | 0.140 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1998 | 4 | 0.140 |
Why?
|
| Cell Movement | 5 | 2022 | 816 | 0.140 |
Why?
|
| Urea | 1 | 2018 | 59 | 0.140 |
Why?
|
| Astrocytes | 3 | 2015 | 151 | 0.140 |
Why?
|
| Complement C4 | 1 | 1998 | 8 | 0.140 |
Why?
|
| Disease Progression | 4 | 2022 | 1559 | 0.140 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2017 | 2 | 0.140 |
Why?
|
| Complement Membrane Attack Complex | 3 | 2007 | 21 | 0.140 |
Why?
|
| Heroin Dependence | 1 | 2017 | 16 | 0.140 |
Why?
|
| Glycation End Products, Advanced | 1 | 2017 | 12 | 0.140 |
Why?
|
| Brain Edema | 3 | 2007 | 61 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2018 | 121 | 0.130 |
Why?
|
| B-Lymphocytes | 4 | 2009 | 760 | 0.130 |
Why?
|
| Lymphocyte Activation | 4 | 2009 | 810 | 0.130 |
Why?
|
| Peritoneal Dialysis | 1 | 2017 | 31 | 0.130 |
Why?
|
| Pancreas | 1 | 1999 | 263 | 0.130 |
Why?
|
| Macrophage-1 Antigen | 1 | 1997 | 18 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1981 | 0.130 |
Why?
|
| Regeneration | 1 | 2018 | 161 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 131 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 277 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2013 | 358 | 0.130 |
Why?
|
| Microglia | 1 | 2017 | 124 | 0.130 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2016 | 7 | 0.130 |
Why?
|
| Autoimmunity | 3 | 2017 | 192 | 0.120 |
Why?
|
| HIV-1 | 1 | 2017 | 182 | 0.120 |
Why?
|
| Liver | 1 | 2021 | 1231 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 394 | 0.120 |
Why?
|
| Epithelial Cells | 3 | 2007 | 705 | 0.120 |
Why?
|
| Fracture Healing | 2 | 2007 | 43 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2018 | 310 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 422 | 0.120 |
Why?
|
| Aquaporin 4 | 2 | 2007 | 9 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2016 | 75 | 0.120 |
Why?
|
| Receptors, Calcitriol | 2 | 2007 | 131 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 100 | 0.120 |
Why?
|
| Diet | 2 | 2017 | 460 | 0.120 |
Why?
|
| Extracellular Matrix | 3 | 2007 | 255 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2018 | 364 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2007 | 149 | 0.110 |
Why?
|
| Glycolysis | 2 | 2007 | 191 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 204 | 0.110 |
Why?
|
| Comorbidity | 2 | 2017 | 1011 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2007 | 89 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2007 | 206 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 325 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2015 | 22 | 0.110 |
Why?
|
| Complement C3d | 2 | 2007 | 6 | 0.110 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 74 | 0.110 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2006 | 7 | 0.110 |
Why?
|
| Sheep | 2 | 2009 | 250 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 281 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 70 | 0.110 |
Why?
|
| Proteinuria | 3 | 2012 | 69 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2007 | 1156 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 3 | 2007 | 349 | 0.100 |
Why?
|
| Female | 12 | 2017 | 49872 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2015 | 415 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2016 | 164 | 0.090 |
Why?
|
| DNA, Complementary | 2 | 2003 | 394 | 0.090 |
Why?
|
| Nephritis | 1 | 2012 | 17 | 0.090 |
Why?
|
| Microbiota | 1 | 2017 | 426 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 648 | 0.090 |
Why?
|
| Precipitin Tests | 3 | 1997 | 108 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2015 | 504 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 367 | 0.090 |
Why?
|
| Gliosis | 2 | 2009 | 32 | 0.090 |
Why?
|
| Protein Isoforms | 2 | 2010 | 296 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 249 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2010 | 290 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 1995 | 257 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2010 | 796 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2010 | 42 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 777 | 0.080 |
Why?
|
| Species Specificity | 3 | 2004 | 707 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 489 | 0.080 |
Why?
|
| Leukocyte Common Antigens | 2 | 2007 | 51 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2018 | 326 | 0.080 |
Why?
|
| Cholesterol | 2 | 2021 | 366 | 0.080 |
Why?
|
| Wound Healing | 2 | 2016 | 378 | 0.080 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 14 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1827 | 0.080 |
Why?
|
| Microvilli | 1 | 2009 | 44 | 0.080 |
Why?
|
| Organic Chemicals | 1 | 2009 | 37 | 0.080 |
Why?
|
| Annexin A4 | 1 | 2009 | 2 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 562 | 0.070 |
Why?
|
| Heymann Nephritis Antigenic Complex | 2 | 2001 | 3 | 0.070 |
Why?
|
| Calcitriol | 2 | 2007 | 173 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 58 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2010 | 430 | 0.070 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 164 | 0.070 |
Why?
|
| Protein Phosphatase 2C | 1 | 2008 | 6 | 0.070 |
Why?
|
| Femoral Fractures | 2 | 2007 | 34 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 176 | 0.070 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Albumins | 1 | 2009 | 135 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2009 | 206 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2009 | 279 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2009 | 181 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 58 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2009 | 1753 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 189 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.070 |
Why?
|
| HIV Infections | 1 | 2017 | 974 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2008 | 215 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 28 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2007 | 16 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 56 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 42 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 49 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 47 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 43 | 0.070 |
Why?
|
| Proteins | 2 | 2003 | 816 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 156 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 66 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 262 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 1029 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 2480 | 0.070 |
Why?
|
| Autoantibodies | 3 | 2009 | 281 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 37 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2007 | 28 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2007 | 25 | 0.070 |
Why?
|
| CD40 Antigens | 1 | 2007 | 44 | 0.070 |
Why?
|
| Prognosis | 1 | 2015 | 3990 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 61 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2007 | 93 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2009 | 830 | 0.070 |
Why?
|
| Horses | 1 | 2007 | 36 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 120 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 22 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 1615 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 47 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 190 | 0.060 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 12 | 0.060 |
Why?
|
| Adipocytes | 1 | 2008 | 170 | 0.060 |
Why?
|
| Calbindin 1 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2006 | 7 | 0.060 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2006 | 10 | 0.060 |
Why?
|
| Calbindins | 1 | 2006 | 16 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 1997 | 84 | 0.060 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2006 | 19 | 0.060 |
Why?
|
| Immediate-Early Proteins | 2 | 2007 | 164 | 0.060 |
Why?
|
| Molecular Weight | 2 | 1997 | 329 | 0.060 |
Why?
|
| Actins | 2 | 2020 | 472 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 192 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2006 | 51 | 0.060 |
Why?
|
| Complement C9 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 526 | 0.060 |
Why?
|
| Feces | 2 | 2018 | 360 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 307 | 0.060 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 34 | 0.060 |
Why?
|
| Choline | 1 | 2005 | 27 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 477 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2005 | 45 | 0.060 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 33 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 52 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 85 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 223 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2015 | 9167 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2007 | 155 | 0.060 |
Why?
|
| Arginine | 1 | 2005 | 144 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2005 | 108 | 0.060 |
Why?
|
| Protons | 1 | 2005 | 104 | 0.060 |
Why?
|
| Glutamine | 1 | 2005 | 99 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2005 | 159 | 0.050 |
Why?
|
| Databases, Protein | 1 | 2005 | 52 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2005 | 44 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 156 | 0.050 |
Why?
|
| Cryoglobulins | 1 | 2004 | 4 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2010 | 124 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 322 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1662 | 0.050 |
Why?
|
| Antigens | 1 | 2005 | 231 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 39 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 103 | 0.050 |
Why?
|
| Procollagen | 1 | 2003 | 8 | 0.050 |
Why?
|
| Ginsenosides | 1 | 2004 | 124 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 327 | 0.050 |
Why?
|
| Hippocampus | 1 | 2007 | 459 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 91 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 46 | 0.050 |
Why?
|
| Complement Pathway, Classical | 1 | 2003 | 2 | 0.050 |
Why?
|
| Phenotype | 3 | 2018 | 2575 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 372 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 294 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 301 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 101 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 615 | 0.050 |
Why?
|
| Nephrosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Puromycin Aminonucleoside | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mice, Inbred NZB | 1 | 2002 | 13 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2002 | 11 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 29 | 0.050 |
Why?
|
| Vasculitis | 1 | 2003 | 40 | 0.050 |
Why?
|
| Rats, Inbred Lew | 2 | 2004 | 214 | 0.050 |
Why?
|
| Dermatitis | 1 | 2003 | 35 | 0.050 |
Why?
|
| Proteomics | 1 | 2005 | 268 | 0.050 |
Why?
|
| Liver Failure | 1 | 2003 | 69 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 19 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 297 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 297 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1809 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2002 | 84 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 2002 | 19 | 0.050 |
Why?
|
| Clodronic Acid | 1 | 2022 | 9 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 84 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2002 | 151 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2002 | 119 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 123 | 0.050 |
Why?
|
| Complement C5b | 1 | 2001 | 2 | 0.040 |
Why?
|
| Complement C3b | 1 | 2001 | 5 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1080 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2005 | 286 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2002 | 148 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2022 | 84 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 311 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2001 | 75 | 0.040 |
Why?
|
| Calcium | 1 | 2006 | 1205 | 0.040 |
Why?
|
| Computational Biology | 1 | 2005 | 586 | 0.040 |
Why?
|
| Mutation | 1 | 2012 | 4374 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 9 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 632 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2020 | 13 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1957 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 235 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2001 | 163 | 0.040 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 80 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 48 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2004 | 873 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2020 | 38 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 687 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 134 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2004 | 464 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 995 | 0.040 |
Why?
|
| Fermentation | 1 | 2000 | 15 | 0.040 |
Why?
|
| Hemolysis | 1 | 2000 | 63 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 197 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2021 | 201 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2000 | 279 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2025 | 766 | 0.040 |
Why?
|
| Chemokine CXCL2 | 2 | 2010 | 16 | 0.040 |
Why?
|
| Genomics | 1 | 2005 | 857 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2002 | 1540 | 0.040 |
Why?
|
| Urease | 1 | 2018 | 3 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2018 | 44 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2018 | 38 | 0.040 |
Why?
|
| Ribotyping | 1 | 2018 | 12 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 563 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2018 | 98 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2018 | 146 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 3 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 101 | 0.030 |
Why?
|
| Immunization | 1 | 1998 | 165 | 0.030 |
Why?
|
| Mating Factor | 1 | 1997 | 4 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 64 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1997 | 62 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 41 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 488 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1997 | 42 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 204 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 1166 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 606 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 170 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1999 | 382 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 686 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 2016 | 44 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 241 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1267 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1997 | 446 | 0.030 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2015 | 3 | 0.030 |
Why?
|
| Claudin-5 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 69 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 80 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 467 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 142 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 124 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 112 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 152 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 930 | 0.030 |
Why?
|
| Neurons | 3 | 2010 | 1653 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2017 | 385 | 0.030 |
Why?
|
| DNA | 2 | 2012 | 1327 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 936 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 137 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 144 | 0.030 |
Why?
|
| Glycosylation | 1 | 1995 | 137 | 0.030 |
Why?
|
| Spleen | 1 | 1995 | 420 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 153 | 0.030 |
Why?
|
| Epithelium | 1 | 1995 | 322 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2385 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 463 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 439 | 0.030 |
Why?
|
| Peptides | 1 | 1997 | 671 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2015 | 201 | 0.030 |
Why?
|
| Atrophy | 1 | 2013 | 131 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2013 | 226 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1995 | 220 | 0.020 |
Why?
|
| Diglycerides | 1 | 2012 | 23 | 0.020 |
Why?
|
| Turkey | 1 | 2012 | 22 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 28208 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 73 | 0.020 |
Why?
|
| Child | 2 | 2015 | 7618 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3639 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 83 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1931 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 156 | 0.020 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2010 | 21 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 766 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 977 | 0.020 |
Why?
|
| Clone Cells | 1 | 2010 | 223 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 706 | 0.020 |
Why?
|
| Germinal Center | 1 | 2010 | 65 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2010 | 88 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 9873 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2536 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 76 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2009 | 18 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 224 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2009 | 68 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 181 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2008 | 14 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 35 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2008 | 54 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 6 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 130 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 100 | 0.020 |
Why?
|
| Streptozocin | 1 | 2007 | 56 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 462 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2007 | 77 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 309 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 517 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 95 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 52 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 32 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 385 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2007 | 66 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 224 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 201 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 264 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2007 | 281 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 1422 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 3106 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2008 | 297 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 5561 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2009 | 541 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2004 | 25 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 53 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2494 | 0.010 |
Why?
|
| Survival | 1 | 2004 | 21 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2004 | 14 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 3360 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 52 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1560 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 198 | 0.010 |
Why?
|
| Neutron Diffraction | 1 | 2003 | 5 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 43 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 3970 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2004 | 144 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2003 | 67 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 692 | 0.010 |
Why?
|
| Solutions | 1 | 2003 | 86 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2003 | 36 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2003 | 131 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2777 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2002 | 35 | 0.010 |
Why?
|
| Sclerosis | 1 | 2002 | 32 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 908 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 701 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2002 | 95 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 435 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 859 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 750 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 276 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1965 | 0.010 |
Why?
|
| Insulin | 1 | 2004 | 1190 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1375 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 7026 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2882 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 1730 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 28578 | 0.010 |
Why?
|